Evidence map›Paper›PMID 42349552›Full record

ArticleMolecular metabolism2026

RNASET2 degrades mRNAs that protect against lipotoxicity.

Shuiling Zhao, Stevens Bontemps, Ryan M Nottingham, Jun Yao, Mariana Acuña, David E Cohen, Alan M Lambowitz, Jean E Schaffer

Abstract read
In one paragraph

Article in Molecular metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuiling ZhaoJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Stevens BontempsJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Ryan M NottinghamDepartments of Molecular Biosciences and Medicine/Oncology, University of Texas at Austin, Austin, TX, USA.
Jun YaoDepartments of Molecular Biosciences and Medicine/Oncology, University of Texas at Austin, Austin, TX, USA.
Mariana AcuñaDepartment of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
David E CohenDepartment of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Alan M LambowitzDepartments of Molecular Biosciences and Medicine/Oncology, University of Texas at Austin, Austin, TX, USA.
Jean E SchafferJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA. Electronic address: jean.schaffer@joslin.harvard.edu.

Funding

Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLDR01DK056626 · NIDDK · YESHIVA UNIVERSITY · PI COHEN, DAVID E. · 2000 to 2024
$10.3M
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLDR01DK103046 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI DAVID E. COHEN, Susan J Hagen · 2015 to 2026
$7.6M
Regulation of Hepatic Lipid and Glucose Metabolism by Phosphatidylcholine TransfeR01DK048873 · NIDDK · YESHIVA UNIVERSITY · PI DAVID E. COHEN · 2003 to 2026
$5.8M
Them1 Inhibitors for the Management of Non-Alcoholic Fatty Liver DiseaseR01DK133988 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI DAVID E. COHEN · 2023 to 2026
$2.0M
NIDDK NIH HHS R01 DK048873NIDDK NIH HHS R01 DK056626NIDDK NIH HHS R01 DK103046NIDDK NIH HHS R01 DK133988
6 · The paper itself

Abstract

objectivesRNASET2 is a lysosomal RNase whose enzymatic function is required for early events in lipotoxicity. However, the endogenous RNA substrates of RNASET2 that modulate lipid-induced cell death are not known. The purpose of this study was to identify RNASET2 substrates that impact lipotoxic stress.

methodsRNA sequencing was used to identify RNAs that increase in abundance in human cells upon RNASET2 knockdown, and actinomycin D assays were used to show that RNASET2 impacted decay rates of these RNAs. We tested for the presence of these RNAs in immunoisolated lysosomes and determined the contribution of the lysosomal membrane transporter SIDT2 in delivery of these RNAs to the lysosome. A role for these RNAs in lipotoxic cell death was directly tested in loss- and gain of function analysis.

resultsRNASET2 knockdown increased steady-state abundance of UCHL3, PFN2 and PRDX3 mRNAs and prolonged their decay rate, leading to increased protein expression. These mRNAs were delivered to the lysosomal lumen by the lysosomal membrane transporter SIDT2 that mediates RNautophagy. While UCHL3 and PFN2 have not previously been implicated in lipotoxic responses, expression of these proteins protected against lipid-induced cell death.

conclusionsOur study identified specific mRNA substrates of RNASET2 and uncovered a previously unexplored function for lysosomes and RNautophagy in regulation of the response to metabolic stress. Moreover, we demonstrated that RNautophagy selectively regulates turnover of specific endogenous RNAs and thereby impacts regulation of gene expression.

Indexed as

RibonucleasesRNA, MessengerHumansLysosomesRNA StabilityTumor Suppressor ProteinsRibonucleasesRNA, MessengerRNASET2 protein, humanTumor Suppressor ProteinsAutophagyGene expressionLipotoxicityLysosomesRNA degradation

Identifiers

PMID42349552
PMCPMC13382051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.